Diagnosis, Diagnostics, Immunodiagnosis & Immunodiagnostics:

11042.  Grant KM, Dunion MH, Yardley V, Skaltsounis AL, Marko D, Eisenbrand G, Croft SL, Meijer L, Mottram JC. Inhibitors of Leishmania mexicana CRK3 cyclin-dependent kinase: chemical library screen and antileishmanial activity. Antimicrob Agents Chemother. 2004 Aug;48(8):3033-42.

11043.  Laharwal MA, Yasin SB, Ahmed SB. Diagnosis of cutaneous leishmaniasis by fine needle aspiration cytology. J Cytol 2004;21(2):103-5.

Pathogenesis:

11044.  Al-Tawfiq JA, AbuKhamsin A. Cutaneous leishmaniasis: a 46-year study of the epidemiology and clinical features in Saudi Arabia (1956-2002). Int J Infect Dis. 2004 Jul;8(4):244-50.

Therapy:

11045.  Rivas L, Moreno J, Canavate C, Alvar J. Virulence and disease in leishmaniasis: what is relevant for the patient? Trends Parasitol. 2004 Jul;20(7):297-301. Review.